|Day Low/High||60.97 / 68.44|
|52 Wk Low/High||60.97 / 172.75|
Jim Cramer is bullish on STMicroelectronics, Intercept Pharmaceuticals, Altria, and Array BioPharma.
Jim Cramer says when this market gets some bad news after its remarkable run, investors have to break out the dominoes to explain the decline.
The Lexington, Mass.-based company unveiled results from its Phase 2a study of ADX-102 in dry eye disease. Other biotech movers in premarket trading on Sept. 12 include Sage Therapeutics and Intercept Pharmaceuticals.
Clovis Oncology, Intercept Pharmaceuticals and Editas Medicine were among the biotech premarket movers on July 31.
Ocaliva represents the first new treatment option in over 20 years for PBC, an autoimmune liver disease that is the leading reason for liver transplantation in women in Canada
Paratek Pharmaceuticals, Immunomedics and Intercept Pharmaceuticals were among the biotech stock movers in premarket trading Tuesday.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.